Biosimilar Global Market Attractiveness, Competitive Landscape and Key Players- Mylan, Inc., Dr. Reddy’s Laboratories, Amgen Inc., Sandoz International GmbH
Biosimilar Global Market added by Reportsweb to its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, July 05, 2018 ) Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs has experienced robust market growth. Some of the factors which are triggering the market growth include growing incidences of diseases, rising demand for biosimilars drugs owing to their cost effectiveness and increasing demand to limit healthcare expenditures. However, stringent government regulations will affect biosimilars investments.
Get sample copy of the Report: http://www.reportsweb.com/inquiry&RW0001564870/sample
Chronic & Autoimmune disorders segment is expected to grow at a highest CAGR during the forecast period owing to increasing incidences of autoimmune disorders. By geography, Europe dominated the global biosimilars market due to growing appearance of new market participants in this region. However, Asia Pacific is anticipated to grow at a highest CAGR during the forecast period due to rising funds towards the expansion of biosimilars market.
Some of the key players in this market include are Mylan, Inc., Dr. Reddy's Laboratories, Amgen Inc., Sandoz International GmbH , Hospira, Inc., Merck KGAA, Celltrion, Inc., Biocon Ltd. , Teva Pharmaceutical Industries Ltd. and Roche Diagnostics.
Enquire about Discount on Report: http://www.reportsweb.com/inquiry&RW0001564870/discount
Table of Content:
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Biosimilar Market, By Product
5.1 Introduction
5.2 Peptides
5.3 Erythropoietin
5.4 Interferon
5.5 Human Growth Hormone
5.6 Monoclonal Antibodies
5.7 Granulocyte Colony Stimulating Factor (G-CSF)
5.8 Insulin
5.9 Other Products
6 Global Biosimilar Market, By Technology
6.1 Introduction
6.2 Bioassay
6.3 Mass Spectrometry
6.4 Nuclear magnetic resonance (NMR) technology
6.5 Recombinant DNA Technology (rDNA technology)
6.6 Western Blotting
6.7 Electrophoresis
6.8 Chromatography
6.8.1 Gas Chromatography (GC)
6.8.2 Protein sequencing
6.8.3 Liquid chromatography (LC)
6.9 Monoclonal Antibodies (MAb) Technology
7 Global Biosimilar Market, By Application
7.1 Introduction
7.2 Growth Hormone Deficiency
7.3 Chronic and Autoimmune Diseases
7.3.1 Leprosy
7.3.2 Rheumatoid arthritis (RA)
7.3.3 Multiple Sclerosis
7.3.4 Diabetes
7.3.5 Acromegaly
7.3.6 Cystic Fibrosis
7.3.7 Neutropenia
7.4 Blood Disorders
7.4.1 Pulmonary embolism
7.4.2 Hemophilia
7.5 Oncology Diseases
7.5.1 Leukaemia
7.5.2 Colorectal Cancer
7.5.3 Breast Cancer
7.5.4 Prostate Cancer
7.5.5 Cervical Cancer
7.5.6 Lungs Cancer
7.6 Other Applications
8 Global Biosimilar Market, By Service
8.1 Introduction
8.2 Clinical Trials
8.2.1 Phase I
8.2.2 Phase II
8.2.3 Phase III
8.3 Contract Research and Manufacturing Services
Know more about Report: http://www.reportsweb.com/biosimilar-global-market-outlook-2016-2022
Get sample copy of the Report: http://www.reportsweb.com/inquiry&RW0001564870/sample
Chronic & Autoimmune disorders segment is expected to grow at a highest CAGR during the forecast period owing to increasing incidences of autoimmune disorders. By geography, Europe dominated the global biosimilars market due to growing appearance of new market participants in this region. However, Asia Pacific is anticipated to grow at a highest CAGR during the forecast period due to rising funds towards the expansion of biosimilars market.
Some of the key players in this market include are Mylan, Inc., Dr. Reddy's Laboratories, Amgen Inc., Sandoz International GmbH , Hospira, Inc., Merck KGAA, Celltrion, Inc., Biocon Ltd. , Teva Pharmaceutical Industries Ltd. and Roche Diagnostics.
Enquire about Discount on Report: http://www.reportsweb.com/inquiry&RW0001564870/discount
Table of Content:
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Biosimilar Market, By Product
5.1 Introduction
5.2 Peptides
5.3 Erythropoietin
5.4 Interferon
5.5 Human Growth Hormone
5.6 Monoclonal Antibodies
5.7 Granulocyte Colony Stimulating Factor (G-CSF)
5.8 Insulin
5.9 Other Products
6 Global Biosimilar Market, By Technology
6.1 Introduction
6.2 Bioassay
6.3 Mass Spectrometry
6.4 Nuclear magnetic resonance (NMR) technology
6.5 Recombinant DNA Technology (rDNA technology)
6.6 Western Blotting
6.7 Electrophoresis
6.8 Chromatography
6.8.1 Gas Chromatography (GC)
6.8.2 Protein sequencing
6.8.3 Liquid chromatography (LC)
6.9 Monoclonal Antibodies (MAb) Technology
7 Global Biosimilar Market, By Application
7.1 Introduction
7.2 Growth Hormone Deficiency
7.3 Chronic and Autoimmune Diseases
7.3.1 Leprosy
7.3.2 Rheumatoid arthritis (RA)
7.3.3 Multiple Sclerosis
7.3.4 Diabetes
7.3.5 Acromegaly
7.3.6 Cystic Fibrosis
7.3.7 Neutropenia
7.4 Blood Disorders
7.4.1 Pulmonary embolism
7.4.2 Hemophilia
7.5 Oncology Diseases
7.5.1 Leukaemia
7.5.2 Colorectal Cancer
7.5.3 Breast Cancer
7.5.4 Prostate Cancer
7.5.5 Cervical Cancer
7.5.6 Lungs Cancer
7.6 Other Applications
8 Global Biosimilar Market, By Service
8.1 Introduction
8.2 Clinical Trials
8.2.1 Phase I
8.2.2 Phase II
8.2.3 Phase III
8.3 Contract Research and Manufacturing Services
Know more about Report: http://www.reportsweb.com/biosimilar-global-market-outlook-2016-2022
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results